Exact Mass: 391.0715

Exact Mass Matches: 391.0715

Found 123 metabolites which its exact mass value is equals to given mass value 391.0715, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Glucoconringiin

{[(e)-(3-hydroxy-3-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulphanyl}butylidene)amino]oxy}sulphonic acid

C11H21NO10S2 (391.0607)


Isolated from Conringia orientalis (hares ear mustard). Glucoconringiin is found in horseradish, fats and oils, and horseradish tree. Glucoconringiin is found in fats and oils. Glucoconringiin is isolated from Conringia orientalis (hares ear mustard).

   

Adenosine phosphate disodium

Adenosine 5′-monophosphate disodium salt

C10H12N5Na2O7P (391.027)


Adenosine 5'-monophosphate disodium is an orally active purine nucleotide, and participates in ATP metabolism. Adenosine 5'-monophosphate disodium is also a ligand for adenosine 2B receptor. Adenosine 5'-monophosphate disodium can activate AMPK in skeletal muscle, and ameliorates insulin resistance and impaired glucose metabolism. Adenosine 5'-monophosphate disodium can be used for research of diabetes[1][2][3]. Adenosine 5'-monophosphate disodium is an orally active purine nucleotide, and participates in ATP metabolism. Adenosine 5'-monophosphate disodium is also a ligand for adenosine 2B receptor. Adenosine 5'-monophosphate disodium can activate AMPK in skeletal muscle, and ameliorates insulin resistance and impaired glucose metabolism. Adenosine 5'-monophosphate disodium can be used for research of diabetes[1][2][3].

   

Chlorohaloperidol

1-(3-(4-Chlorobenzoyl)propyl)-4-hydroxy-4-(4-chlorophenyl)piperidine hydrochloride

C21H23Cl2NO2 (391.1106)


   

N-4-Carboxybenzylglucamine dithiocarbamate

4-{[(2,3,4,5,6-pentahydroxyhexyl)[sulfanyl(carbonothioyl)]amino]methyl}benzoic acid

C15H21NO7S2 (391.0759)


   

Zidebactam

(1R,2S,5R)-7-oxo-2-(2-((R)-Piperidine-3-carbonyl)hydrazinecarbonyl)-1,6-diazabicyclo[3.2.1]octan-6-yl hydrogen sulfate

C13H21N5O7S (391.1162)


   

5-Chloro-2-hydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one beta-D-glucopyranoside

5-chloro-7-methoxy-2-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1,4-benzoxazin-3-one

C15H18ClNO9 (391.067)


5-chloro-2-hydroxy-7-methoxy-2h-1,4-benzoxazin-3(4h)-one beta-d-glucopyranoside is soluble (in water) and a very weakly acidic compound (based on its pKa). 5-chloro-2-hydroxy-7-methoxy-2h-1,4-benzoxazin-3(4h)-one beta-d-glucopyranoside can be found in corn, which makes 5-chloro-2-hydroxy-7-methoxy-2h-1,4-benzoxazin-3(4h)-one beta-d-glucopyranoside a potential biomarker for the consumption of this food product.

   

[1,3]Benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridine-14-aceticacid, 13,14-dihydro-13-methyl-, (+)-

[1,3]Benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridine-14-aceticacid, 13,14-dihydro-13-methyl-, (+)-

C22H17NO6 (391.1056)


   

Glucosisaustricin

1-Ethyl-2-hydroxyethyl glucosinolate

C11H21NO10S2 (391.0607)


   

4-Hydroxybutylglucosinolate

4-Hydroxybutylglucosinolate

C11H21NO10S2 (391.0607)


   

3-Hydroxybutyl glucosinolate

3-Hydroxybutyl glucosinolate

C11H21NO10S2 (391.0607)


   

1-(Hydroxymethyl)propyl glucosynolate

1-(Hydroxymethyl)propyl glucosynolate

C11H21NO10S2 (391.0607)


   
   

3-[4-Methoxy-2-(trifluoromethyl)-6-quinolyl]prop-2-ynyl thiophene-2-carboxylate

3-[4-Methoxy-2-(trifluoromethyl)-6-quinolyl]prop-2-ynyl thiophene-2-carboxylate

C19H12F3NO3S (391.049)


   
   

Maybridge4_001810

Maybridge4_001810

C19H13N5O3S (391.0739)


   
   
   

PRZ_M392a

PRZ_M392a

C15H16Cl3N3O3 (391.0257)


CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2006

   

Triphenyltin chloride

Triphenyltin chloride

C18H20ClSn+ (391.0275)


   

(2S)-beta-D-2-Amino-3-[[5-deoxy-5-(dimethylarsinoyl)ribofruanosyl]oxy]-1-propanesulfonic acid

(2S)-beta-D-2-Amino-3-[[5-deoxy-5-(dimethylarsinoyl)ribofruanosyl]oxy]-1-propanesulfonic acid

C10H22AsNO8S (391.0282)


   

Antibiotic A 33853

Antibiotic A 33853

C20H13N3O6 (391.0804)


   
   

2-(5-chloro-2-hydroxy-7-methoxy-2H-1,4-benzoxazin-3<4H>-one)-beta-D-glucopyranoside|2-(5-chloro-2-hydroxy-7-methoxy-2H-1,4-benzoxazin-3[4H]-one)-beta-D-glucopyranoside

2-(5-chloro-2-hydroxy-7-methoxy-2H-1,4-benzoxazin-3<4H>-one)-beta-D-glucopyranoside|2-(5-chloro-2-hydroxy-7-methoxy-2H-1,4-benzoxazin-3[4H]-one)-beta-D-glucopyranoside

C15H18ClNO9 (391.067)


   

PRZ_M392b

PRZ_M392b

C15H16Cl3N3O3 (391.0257)


CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2005

   
   

His-Asn-OH

(S)-2-(3-(2-(1H-imidazol-4-yl)ethoxy)-4-nitrobenzamido)-5-amino-5-oxopentanoic acid

C16H17N5O7 (391.1128)


   
   

3-[[4-[(2,6-dichloro-4-nitrophenyl)azo]phenyl]ethylamino]propiononitrile

3-[[4-[(2,6-dichloro-4-nitrophenyl)azo]phenyl]ethylamino]propiononitrile

C17H15Cl2N5O2 (391.0603)


   
   

Eberconazole nitrate

Eberconazole nitrate

C18H15Cl2N3O3 (391.049)


   

Boc-Phe(2-I)-OH

Boc-Phe(2-I)-OH

C14H18INO4 (391.0281)


   

(9H-FLUOREN-9-YL)METHYL 4-CHLORO-7,8-DIHYDROPYRIDO[4,3-D]PYRIMIDINE-6(5H)-CARBOXYLATE

(9H-FLUOREN-9-YL)METHYL 4-CHLORO-7,8-DIHYDROPYRIDO[4,3-D]PYRIMIDINE-6(5H)-CARBOXYLATE

C22H18ClN3O2 (391.1087)


   

(E)-4-[3,4-bis(4-chlorophenyl)butan-2-ylamino]-4-oxobut-2-enoic acid

(E)-4-[3,4-bis(4-chlorophenyl)butan-2-ylamino]-4-oxobut-2-enoic acid

C20H19Cl2NO3 (391.0742)


   

naphthol as-tr phosphate

naphthol as-tr phosphate

C18H15ClNO5P (391.0376)


   

TIARAMIDE HYDROCHLORIDE

TIARAMIDE HYDROCHLORIDE

C15H19Cl2N3O3S (391.0524)


D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

Rabeprazole Sulfone N-Oxide

Rabeprazole Sulfone N-Oxide

C18H21N3O5S (391.1202)


   

GRI 977143

2-((3-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)propyl)thio)benzoic acid

C22H17NO4S (391.0878)


   

Sodium 2-methyl-3-[(5-methyl-1,3-thiazol-2-yl)carbamoyl]-2H-1,2-b enzothiazin-4-olate 1,1-dioxide hydrate (1:1:1)

Sodium 2-methyl-3-[(5-methyl-1,3-thiazol-2-yl)carbamoyl]-2H-1,2-b enzothiazin-4-olate 1,1-dioxide hydrate (1:1:1)

C14H14N3NaO5S2 (391.0273)


   

1,3-di-boc-2-(trifluoromethylsulfonyl)guanidine

1,3-di-boc-2-(trifluoromethylsulfonyl)guanidine

C12H20F3N3O6S (391.1025)


   

Boc-d-phe(3-i)-oh

Boc-d-phe(3-i)-oh

C14H18INO4 (391.0281)


   

Boc-D-4-iodophenylalanine

Boc-D-4-iodophenylalanine

C14H18INO4 (391.0281)


   

4-[(2,4-Dichloro-5-methoxyphenyl)amino]-7-fluoro-6-methoxy-3-quinolinecarbonitrile

4-[(2,4-Dichloro-5-methoxyphenyl)amino]-7-fluoro-6-methoxy-3-quinolinecarbonitrile

C18H12Cl2FN3O2 (391.0291)


   

2H-Pyrrol-2-one, 4-acetyl-1-(4-chlorophenyl)-5-(1,4-dioxaspiro[4.5]dec-8-yl)-1,5-dihydro-3-hydroxy-

2H-Pyrrol-2-one, 4-acetyl-1-(4-chlorophenyl)-5-(1,4-dioxaspiro[4.5]dec-8-yl)-1,5-dihydro-3-hydroxy-

C20H22ClNO5 (391.1186)


   

(S)-(3-(3,4-DICHLOROPHENYL)-3-(3-HYDROXYPROPYL)PIPERIDIN-1-YL)(PHENYL)METHANONE

(S)-(3-(3,4-DICHLOROPHENYL)-3-(3-HYDROXYPROPYL)PIPERIDIN-1-YL)(PHENYL)METHANONE

C21H23Cl2NO2 (391.1106)


   
   

Tonabersat

Tonabersat

C20H19ClFNO4 (391.0987)


C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent

   

Disperse Yellow brown Se-4br Wet Cake

Disperse Yellow brown Se-4br Wet Cake

C17H15Cl2N5O2 (391.0603)


   

N-(3-NITRO-2-PYRIDINESULFENYL)-O-T-BUTYL-L-TYROSINE

N-(3-NITRO-2-PYRIDINESULFENYL)-O-T-BUTYL-L-TYROSINE

C18H21N3O5S (391.1202)


   

Disodium 2-deoxy-5-O-phosphonatoguanosine

Disodium 2-deoxy-5-O-phosphonatoguanosine

C10H12N5Na2O7P (391.027)


2'-Deoxyguanosine 5'-monophosphate disodium (5′-dGMP disodium) is a mononucleotide having guanine as the nucleobase. 2'-Deoxyguanosine 5'-monophosphate disodium is a nucleic acid guanosine triphosphate (GTP) derivative[1].

   

1-(3,4-Dichlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid

1-(3,4-Dichlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid

C19H15Cl2NO4 (391.0378)


   

Boc-4-Iodo-L-phenylalanine

Boc-4-Iodo-L-phenylalanine

C14H18INO4 (391.0281)


   

boc-phe(3-i)-oh

boc-phe(3-i)-oh

C14H18INO4 (391.0281)


   

Zidebactam

Zidebactam

C13H21N5O7S (391.1162)


C254 - Anti-Infective Agent > C258 - Antibiotic

   

2-C-Methyl-6-O-methyl-5-guanylic acid

2-C-Methyl-6-O-methyl-5-guanylic acid

C12H18N5O8P (391.0893)


   

tert-butyl 2-methyl-2-(5-methyl-6-(oxazol-2-yl)-2,4-dioxo-1,2-dihydrothieno[2,3-d]pyrimidin-3(4H)-yl)propanoate

tert-butyl 2-methyl-2-(5-methyl-6-(oxazol-2-yl)-2,4-dioxo-1,2-dihydrothieno[2,3-d]pyrimidin-3(4H)-yl)propanoate

C18H21N3O5S (391.1202)


   

5-ETHYL-5 6-DIHYDRO-3 8-DINITRO-6-PHENY&

5-ETHYL-5 6-DIHYDRO-3 8-DINITRO-6-PHENY&

C21H17N3O5 (391.1168)


   

(1R,3S,4S)-3-(6-BroMo-1H-benziMidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-diMethylethyl ester

(1R,3S,4S)-3-(6-BroMo-1H-benziMidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-diMethylethyl ester

C18H22BrN3O2 (391.0895)


   

Boc-D-Phe(2-I)-OH

Boc-D-Phe(2-I)-OH

C14H18INO4 (391.0281)


   
   

N-SUCCINYL-GLY-GLY-GLY P-NITROANILIDE

N-SUCCINYL-GLY-GLY-GLY P-NITROANILIDE

C16H17N5O7 (391.1128)


   

(2,3,4,5,6-pentafluorophenyl) 1-(thiophen-2-ylmethyl)piperidine-4-carboxylate

(2,3,4,5,6-pentafluorophenyl) 1-(thiophen-2-ylmethyl)piperidine-4-carboxylate

C17H14F5NO2S (391.0665)


   

Methyl-2-bromo-3-{4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl} propionate

Methyl-2-bromo-3-{4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl} propionate

C19H22BrNO3 (391.0783)


   

nalorphine hydrobromide

nalorphine hydrobromide

C19H22BrNO3 (391.0783)


   

Tavapadon

Tavapadon

C19H16F3N3O3 (391.1144)


C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist (Rac)-Tavapadon ((Rac)-PF-06649751) is a potent and selective noncatechol dopamine D1 receptor agonist. (Rac)-Tavapadon displays potent full agonism in the GS activation assay as well as partial agonism in the β-arrestin2 recruitment assay (GS-cAMP, EC50=0.8 nM; β-arrestin2, EC50=68 nM). (Rac)-Tavapadon has antiparkinsonian activity[1]. Tavapadon (PF-06649751) is an orally active and highly selective dopamine D1/D5 receptor partial agonist. Tavapadon is effective in enabling movement and reducing disability and has the potential for Parkinson's disease[1].

   

n-Hydroxy-2-[4-(4-phenoxy-benzenesulfonyl)-tetrahydro-pyran-4-yl]-acetamide

n-Hydroxy-2-[4-(4-phenoxy-benzenesulfonyl)-tetrahydro-pyran-4-yl]-acetamide

C19H21NO6S (391.109)


   
   

N(2),N(2)-dimethylguanosine 5-monophosphate

N(2),N(2)-dimethylguanosine 5-monophosphate

C12H18N5O8P (391.0893)


   

N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]-2-[[1-(3-methylphenyl)-2-imidazolyl]thio]acetamide

N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]-2-[[1-(3-methylphenyl)-2-imidazolyl]thio]acetamide

C16H17N5OS3 (391.0595)


   

2-[[5-(5-chloro-2-thiophenyl)-1,3,4-oxadiazol-2-yl]thio]-1-(3,4-dihydro-2H-quinolin-1-yl)ethanone

2-[[5-(5-chloro-2-thiophenyl)-1,3,4-oxadiazol-2-yl]thio]-1-(3,4-dihydro-2H-quinolin-1-yl)ethanone

C17H14ClN3O2S2 (391.0216)


   

5-(4-Fluorophenyl)-3-{[(4-methylphenyl)sulfonyl]amino}thiophene-2-carboxylic acid

5-(4-Fluorophenyl)-3-{[(4-methylphenyl)sulfonyl]amino}thiophene-2-carboxylic acid

C18H14FNO4S2 (391.0348)


   

Acetosulfone sodium

Acetosulfone sodium

C14H14N3NaO5S2 (391.0273)


C254 - Anti-Infective Agent > C849 - Sulfone Anti-Infective Agent

   

Vidarabine sodium phosphate

Vidarabine sodium phosphate

C10H12N5Na2O7P (391.027)


C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent

   

2-naphthol 6-O-malonylglucoside

2-naphthol 6-O-malonylglucoside

C19H19O9- (391.1029)


   

1-naphthol 6-O-malonylglucoside

1-naphthol 6-O-malonylglucoside

C19H19O9- (391.1029)


   

2-(glutathion-S-yl)-2-carboxypropane

2-(glutathion-S-yl)-2-carboxypropane

C14H21N3O8S-2 (391.1049)


   

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-5-hydroxy-N-sulfooxypentanimidothioate

[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1E)-5-hydroxy-N-sulfooxypentanimidothioate

C11H21NO10S2 (391.0607)


   

5-Chloro-2-hydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one beta-D-glucopyranoside

5-Chloro-2-hydroxy-7-methoxy-2H-1,4-benzoxazin-3(4H)-one beta-D-glucopyranoside

C15H18ClNO9 (391.067)


   

1-S-[3-hydroxy-3-methyl-N-(sulfooxy)butanimidoyl]-1-thio-beta-D-glucopyranose

1-S-[3-hydroxy-3-methyl-N-(sulfooxy)butanimidoyl]-1-thio-beta-D-glucopyranose

C11H21NO10S2 (391.0607)


   

4-Chlorobenzoic acid 2-(2-amino-3-cyano-1-pyrrolo[3,2-b]quinoxalinyl)ethyl ester

4-Chlorobenzoic acid 2-(2-amino-3-cyano-1-pyrrolo[3,2-b]quinoxalinyl)ethyl ester

C20H14ClN5O2 (391.0836)


   

2-[[2-(4-chlorophenoxy)-1-oxoethyl]hydrazo]-N-(2-methoxy-5-methylphenyl)-2-oxoacetamide

2-[[2-(4-chlorophenoxy)-1-oxoethyl]hydrazo]-N-(2-methoxy-5-methylphenyl)-2-oxoacetamide

C18H18ClN3O5 (391.0935)


   

N-(2-chloro-3-pyridinyl)-2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]thio]acetamide

N-(2-chloro-3-pyridinyl)-2-[[5-(3-methylanilino)-1,3,4-thiadiazol-2-yl]thio]acetamide

C16H14ClN5OS2 (391.0328)


   

3-[(4-Bromophenyl)methyl]-4-(4-methoxyanilino)-4-oxobutanoic acid

3-[(4-Bromophenyl)methyl]-4-(4-methoxyanilino)-4-oxobutanoic acid

C18H18BrNO4 (391.0419)


   

2-[2-[2-(4-Chlorophenyl)-2-oxoethoxy]phenyl]isoindole-1,3-dione

2-[2-[2-(4-Chlorophenyl)-2-oxoethoxy]phenyl]isoindole-1,3-dione

C22H14ClNO4 (391.0611)


   

4-[5-(4-morpholinylsulfonyl)-2-thiophenyl]-3-phenyl-2H-furan-5-one

4-[5-(4-morpholinylsulfonyl)-2-thiophenyl]-3-phenyl-2H-furan-5-one

C18H17NO5S2 (391.0548)


   

N-[4-(4-methoxyphenyl)-2-thiazolyl]-5-methyl-2-phenyl-4-oxazolecarboxamide

N-[4-(4-methoxyphenyl)-2-thiazolyl]-5-methyl-2-phenyl-4-oxazolecarboxamide

C21H17N3O3S (391.0991)


   

N-(3,5-dichloro-2-pyridinyl)-2-[(4-methyl-2-quinolinyl)thio]propanamide

N-(3,5-dichloro-2-pyridinyl)-2-[(4-methyl-2-quinolinyl)thio]propanamide

C18H15Cl2N3OS (391.0313)


   

N-[(2-methyl-3-nitrophenyl)-oxomethyl]-2-(4-morpholinyl)-4-thiazolecarbohydrazide

N-[(2-methyl-3-nitrophenyl)-oxomethyl]-2-(4-morpholinyl)-4-thiazolecarbohydrazide

C16H17N5O5S (391.095)


   

5-(2,5-dichlorophenyl)-N-(2,6-dimethoxyphenyl)-2-furancarboxamide

5-(2,5-dichlorophenyl)-N-(2,6-dimethoxyphenyl)-2-furancarboxamide

C19H15Cl2NO4 (391.0378)


   

N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-[[5-[(3-methylphenoxy)methyl]-1,3,4-oxadiazol-2-yl]thio]acetamide

N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-[[5-[(3-methylphenoxy)methyl]-1,3,4-oxadiazol-2-yl]thio]acetamide

C16H17N5O3S2 (391.0773)


   

2-[(4Z)-2,5-dioxo-4-[[1-(4-phosphonophenyl)pyrrol-2-yl]methylidene]imidazolidin-1-yl]acetic acid

2-[(4Z)-2,5-dioxo-4-[[1-(4-phosphonophenyl)pyrrol-2-yl]methylidene]imidazolidin-1-yl]acetic acid

C16H14N3O7P (391.0569)


   

N-prop-2-ynyl-2,5-bis(2,2,2-triluoroethoxy)benzenesulonamide

N-prop-2-ynyl-2,5-bis(2,2,2-triluoroethoxy)benzenesulonamide

C13H11F6NO4S (391.0313)


   

3-fluoro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

3-fluoro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

C18H18FN3O4S (391.1002)


   

3-fluoro-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

3-fluoro-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

C18H18FN3O4S (391.1002)


   

3-fluoro-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

3-fluoro-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1,3-thiazol-2-ylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

C18H18FN3O4S (391.1002)


   

3-fluoro-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

3-fluoro-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

C18H18FN3O4S (391.1002)


   

3-fluoro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

3-fluoro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

C18H18FN3O4S (391.1002)


   

3-fluoro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

3-fluoro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

C18H18FN3O4S (391.1002)


   

3-fluoro-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

3-fluoro-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

C18H18FN3O4S (391.1002)


   

3-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

3-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzamide

C18H18FN3O4S (391.1002)


   

(S)-eberconazole nitrate

(S)-eberconazole nitrate

C18H15Cl2N3O3 (391.049)


   

(R)-eberconazole nitrate

(R)-eberconazole nitrate

C18H15Cl2N3O3 (391.049)


   

Glucoconringiin

Glucoconringiin

C11H21NO10S2 (391.0607)


A hydroxy-alkylglucosinolic acid that consists of 1-thio-beta-D-glucopyranose attached to a 3-hydroxy-3-methyl-N-(sulfooxy)butanimidoyl group at the anomeric sulfur.

   

AZ 12216052

AZ 12216052

C19H22BrNOS (391.0605)


AZ 12216052 is a mGluR8 positive allosteric modulator, and helps mGluR8 modulate signaling inputing to retinal ganglion cells. AZ 12216052 exhibits antianxiety effect[1][2][3][4].

   

CAY10698

CAY10698

C17H17N3O4S2 (391.066)


CAY10698 (compound 1) is a potent and selective inhibitor of 12-Lipoxygenase (12-LOX) with an IC50 of 5.1 μM. CAY10698 is inactive against 5-LOX, 15-LOX-1, 15-LOX-2 and COX-1/2[1].

   

CTEP

CTEP

C19H13ClF3N3O (391.0699)


CTEP (RO 4956371) is a novel, long-acting, orally bioavailable allosteric antagonist of mGlu5 receptor with IC50 of 2.2 nM, and shows > 1000-fold selectivity over other mGlu receptors. CTEP is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

   

2-{2-[2-(2-hydroxyphenyl)-5-methyl-4,5-dihydro-1,3-oxazol-4-yl]-4,5-dihydro-1,3-thiazol-5-yl}-4,5-dihydro-1,3-thiazole-4-carboxylic acid

2-{2-[2-(2-hydroxyphenyl)-5-methyl-4,5-dihydro-1,3-oxazol-4-yl]-4,5-dihydro-1,3-thiazol-5-yl}-4,5-dihydro-1,3-thiazole-4-carboxylic acid

C17H17N3O4S2 (391.066)


   

n-(2-{[2-hydroxy-6-(methoxycarbonyl)phenyl]-c-hydroxycarbonimidoyl}phenyl)pyridine-3-carboximidic acid

n-(2-{[2-hydroxy-6-(methoxycarbonyl)phenyl]-c-hydroxycarbonimidoyl}phenyl)pyridine-3-carboximidic acid

C21H17N3O5 (391.1168)


   

[(e)-(3-hydroxy-3-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}butylidene)amino]oxysulfonic acid

[(e)-(3-hydroxy-3-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}butylidene)amino]oxysulfonic acid

C11H21NO10S2 (391.0607)


   

[(e)-(5-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pentylidene)amino]oxysulfonic acid

[(e)-(5-hydroxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}pentylidene)amino]oxysulfonic acid

C11H21NO10S2 (391.0607)


   

[(23s)-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-yl]acetic acid

[(23s)-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-yl]acetic acid

C22H17NO6 (391.1056)


   

[(23r)-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-yl]acetic acid

[(23r)-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-yl]acetic acid

C22H17NO6 (391.1056)


   

2-amino-3-({5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl}oxy)propane-1-sulfonic acid

2-amino-3-({5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl}oxy)propane-1-sulfonic acid

C10H22AsNO8S (391.0282)


   

(2s,3r,4s,5s,6r)-2-{[(2s)-5-chloro-3-hydroxy-7-methoxy-2h-1,4-benzoxazin-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[(2s)-5-chloro-3-hydroxy-7-methoxy-2h-1,4-benzoxazin-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C15H18ClNO9 (391.067)


   

2-[5-hydroxy-1-(1-hydroxyethyl)-3-methyl-4,9-dioxobenzo[f]isoindol-2-yl]benzoic acid

2-[5-hydroxy-1-(1-hydroxyethyl)-3-methyl-4,9-dioxobenzo[f]isoindol-2-yl]benzoic acid

C22H17NO6 (391.1056)


   

[(e)-(3-hydroxy-3-methyl-1-{[(2r,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}butylidene)amino]oxysulfonic acid

[(e)-(3-hydroxy-3-methyl-1-{[(2r,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}butylidene)amino]oxysulfonic acid

C11H21NO10S2 (391.0607)


   

{24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-yl}acetic acid

{24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-yl}acetic acid

C22H17NO6 (391.1056)


   

[(3-hydroxy-3-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}butylidene)amino]oxysulfonic acid

[(3-hydroxy-3-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}butylidene)amino]oxysulfonic acid

C11H21NO10S2 (391.0607)


   

[(3-hydroxy-3-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}butylidene)amino]oxysulfonic acid

[(3-hydroxy-3-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}butylidene)amino]oxysulfonic acid

C11H21NO10S2 (391.0607)


   

(2s)-2-amino-3-{[(2r,3r,4s,5s)-5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl]oxy}propane-1-sulfonic acid

(2s)-2-amino-3-{[(2r,3r,4s,5s)-5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl]oxy}propane-1-sulfonic acid

C10H22AsNO8S (391.0282)


   

4-[5-hydroxy-1-(1-hydroxyethyl)-3-methyl-4,9-dioxobenzo[f]isoindol-2-yl]benzoic acid

4-[5-hydroxy-1-(1-hydroxyethyl)-3-methyl-4,9-dioxobenzo[f]isoindol-2-yl]benzoic acid

C22H17NO6 (391.1056)


   

2-[(5-chloro-3-hydroxy-7-methoxy-2h-1,4-benzoxazin-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[(5-chloro-3-hydroxy-7-methoxy-2h-1,4-benzoxazin-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C15H18ClNO9 (391.067)


   

n-(2-hydroxy-5-{[8-(hydroxymethyl)-3-oxophenoxazin-2-yl]amino}phenyl)ethanimidic acid

n-(2-hydroxy-5-{[8-(hydroxymethyl)-3-oxophenoxazin-2-yl]amino}phenyl)ethanimidic acid

C21H17N3O5 (391.1168)